Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-07-01
著者
-
TAIRA Shinichiro
Department of Fifth Surgery, Hachioji Medical Center, Tokyo Medical University
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Watanabe Chie
Department Of Molecular Immunology Research Institute For Microbial Diseases And Crest Program Of Js
-
Terui Shoji
国立がんセンター中央病院
-
Hatake Kiyohiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
TSUTSUMI Chizuko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
Takahashi Shunji
Cancer Inst. Hospital Tokyo Jpn
-
Hatake Kiyohiko
Division Of Medical Oncology Cancer Institute Hospital
-
Hatake Kiyohiko
Department Of Hematology Jichi Medical School
-
TAKAYAMA Shin
Department of Surgery
-
INOUE Kenichi
Department of Breast Oncology, Saitama Cancer Center
-
Ito Yoshinori
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Shiba Tadayoshi
Department Of Molecular Biology Kitasato University
-
Hirata Kouichi
First Department Of Surgery Sapporo Medical College
-
Takahashi Shunji
Department Of Oncology And Hematology Cancer Institute Hospital
-
Takahashi Shunji
Department Of Anesthesiology Nagasaki University School Of Medicine
-
Hatake Kiyohiko
Olympus Bio-imaging Laboratory The Cancer Chemotherapy Center Of The Jfcr
-
Hatake Kiyohiko
Department Of Medical Oncology Ariake Cancer Institute Hospital
-
Tokudome Nahomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Biomedical Food Research National Institute Of Infectious Diseasea(former National Ins
-
Tokudome Nahomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Ito Yoshinori
Departments Of Pathology Medical Oncology And Breast Oncology The Cancer Institute Hospital Of The J
-
Oba Masaru
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
KOBAYASHI Kokoro
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
OTO Masafumi
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
KUWAYAMA Akiko
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
MASUMURA Kyoko
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
NAKAYAMA Yoshie
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
Oto Masafumi
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Masumura Kyoko
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Kuwayama Akiko
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Nakayama Yoshie
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Kobayashi Kokoro
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Inoue Kenichi
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Tsutsumi Chizuko
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Ito Yoshinori
Department Of Biochemistry Nagoya City University Medical School
-
Taira Shinichiro
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Watanabe Chie
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Breast Oncology The Cancer Institute Hospital Of The Japanese Foundation For Cancer Research
-
TSUTSUMI Chizuko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute Nagasaki University Graduate School of Biosciences
関連論文
- Cancer of Unknown Primary Site:A Review of 28 Cases and the Efficacy of Cisplatin/Docetaxel Therapy at a Single Institute in Japan
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Inhibitory Mechanisms of Glycoprotein Fraction Derived from Miscanthus sinensis for the Immediate Phase Response of an IgE-Mediated Cutaneous Reaction
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan